Donate For Public and Patients Store Search

D003 - Controversies in Acne and Rosacea

Saturday, March 2; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Integrate the use of spironolactone in the treatment of women with acne by being able to explain controversies surrounding the black box cancer warning, dosing, and monitoring/limiting side effects.
  • Formulate a successful plan to treat moderate to severe acne with minimal use of antibiotics. Assessment of evidence relating to isotretinoin dosing, treatment duration, side effects and laboratory monitoring will be included.
  • Explain the deficiencies of the new (2017) classification system of rosacea and why this matters in patient care.

Description

The management of moderate to severe acne is changing due to the need to limit the use of oral antibiotics. Alternate effective medications and tactics to successfully clear patients will be explored and evidence related to patient selection, dosing, side effects, laboratory monitoring and expected outcomes will be addressed. The new rosacea classification has weaknesses which affect the successful outcome of therapy. Controversies regarding issues in these two common conditions will be discussed with audience exchange an important aspect of this session.

Disclosures

  • James, William D., MD: Elsevier Inc. – O(OB); WebMD – O(H);
Schedule
Saturday, March 2
9:00 AM
Dr. James / Controversies in Acne and Rosacea
Event Details
  • Date
    Saturday, March 2
  • Time
    9:00 AM - 11:00 AM
  • Location
    Room 209A
  • CME Credits
    2.00
  • Type
    MOC
    New
Directors/Co-Directors
  • William D. James, MD, FAAD